These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 39277950)
1. Dual role of triglyceride structures facilitates anti-tumor drug delivery: Both as a self-assembling module and a responsive module. Zhong W; Xu Y; Wang Z; Wang X; Li Y; Liu J; Zhao C; Shi X; He Z; Sun B; Tian C J Colloid Interface Sci; 2025 Jan; 678(Pt C):24-34. PubMed ID: 39277950 [TBL] [Abstract][Full Text] [Related]
2. Exploring the optimal chain length of modification module in disulfide bond bridged paclitaxel prodrug nanoassemblies for breast tumor treatment. Wang D; Huang Y; Yuan J; Wang S; Sheng J; Zhao Y; Zhang H; Wang X; Yu Y; Shi X; He Z; Liu T; Sun B; Sun J J Control Release; 2024 Nov; 375():47-59. PubMed ID: 39222794 [TBL] [Abstract][Full Text] [Related]
3. Fluorinated paclitaxel prodrugs for potentiated stability and chemotherapy. Jiang B; Hao D; Li C; Lu S; Pei Q; Xie Z J Mater Chem B; 2021 Dec; 9(48):9971-9979. PubMed ID: 34871339 [TBL] [Abstract][Full Text] [Related]
4. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery. Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878 [TBL] [Abstract][Full Text] [Related]
5. Revealing the impact of modified modules flexibility on gemcitabine prodrug nanoassemblies for effective cancer therapy. Guo J; Zhang X; Dong F; Wang S; Wang D; Li Y; Zuo S; Wang Q; Li W; Sun J; He Z; Zhang T; Jiang Q; Sun B J Colloid Interface Sci; 2025 Jan; 677(Pt A):941-952. PubMed ID: 39128288 [TBL] [Abstract][Full Text] [Related]
6. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers. Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983 [TBL] [Abstract][Full Text] [Related]
7. Self-Assembly Dual-Responsive NO Donor Nanoparticles for Effective Cancer Therapy. Gu G; Chen C; Zhang S; Yin B; Wang J ACS Appl Mater Interfaces; 2021 Nov; 13(43):50682-50694. PubMed ID: 34668695 [TBL] [Abstract][Full Text] [Related]
8. Triglyceride-Mimetic Structure-Gated Prodrug Nanoparticles for Smart Cancer Therapy. Tian C; Guo J; Miao Y; Zheng S; Sun B; Sun M; Ye Q; Liu W; Zhou S; Kamei KI; He Z; Sun J J Med Chem; 2021 Nov; 64(21):15936-15948. PubMed ID: 34723524 [TBL] [Abstract][Full Text] [Related]
9. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System. Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660 [TBL] [Abstract][Full Text] [Related]
10. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy. Sun B; Luo C; Yu H; Zhang X; Chen Q; Yang W; Wang M; Kan Q; Zhang H; Wang Y; He Z; Sun J Nano Lett; 2018 Jun; 18(6):3643-3650. PubMed ID: 29726685 [TBL] [Abstract][Full Text] [Related]
11. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency. Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011 [TBL] [Abstract][Full Text] [Related]
12. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity. Wang Y; Xin D; Liu K; Zhu M; Xiang J Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889 [TBL] [Abstract][Full Text] [Related]
13. Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy. Sun B; Luo C; Zhang X; Guo M; Sun M; Yu H; Chen Q; Yang W; Wang M; Zuo S; Chen P; Kan Q; Zhang H; Wang Y; He Z; Sun J Nat Commun; 2019 Jul; 10(1):3211. PubMed ID: 31324811 [TBL] [Abstract][Full Text] [Related]
14. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy. Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058 [TBL] [Abstract][Full Text] [Related]
15. Fine-Tuning the Linear Release Rate of Paclitaxel-Bearing Supramolecular Filament Hydrogels through Molecular Engineering. Chakroun RW; Wang F; Lin R; Wang Y; Su H; Pompa D; Cui H ACS Nano; 2019 Jul; 13(7):7780-7790. PubMed ID: 31117370 [TBL] [Abstract][Full Text] [Related]
16. Self-Assembly of pH-Labile Polymer Nanoparticles for Paclitaxel Prodrug Delivery: Formulation, Characterization, and Evaluation. Levit SL; Gade NR; Roper TD; Yang H; Tang C Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291475 [TBL] [Abstract][Full Text] [Related]
17. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy. Zhang L; Qian M; Cui H; Zeng S; Wang J; Chen Q ACS Appl Mater Interfaces; 2021 Feb; 13(5):6053-6068. PubMed ID: 33525873 [TBL] [Abstract][Full Text] [Related]
18. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer. Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051 [TBL] [Abstract][Full Text] [Related]
19. Carboxylated paclitaxel prodrug nanofibers for enhanced chemotherapy. Lu S; Hao D; Xiang X; Pei Q; Xie Z J Control Release; 2023 Mar; 355():528-537. PubMed ID: 36787820 [TBL] [Abstract][Full Text] [Related]
20. Probing the fluorination effect on the self-assembly characteristics, Wang X; Yang B; Li L; Liu T; Zuo S; Chi D; He Z; Sun B; Sun J Theranostics; 2021; 11(16):7896-7910. PubMed ID: 34335971 [No Abstract] [Full Text] [Related] [Next] [New Search]